The
deadly viruses that threaten human survival
Could
the next big animal-human disease wipe us out?
The
Marburg virus: 'If tourists were tripping in and out of some
python-infested Marburg repository, unprotected, and then boarding
their return flights to other continents… it was an international
threat.' Photograph: Science Photo Library
28
September, 2012
Astrid
Joosten was a 41-year-old Dutch woman who, in June 2008, went to
Uganda with her husband. At home in Noord-Brabant, she worked as
a business analyst. Both she and her husband, Jaap Taal, a financial
manager, enjoyed annual adventures, especially to Africa.
The journey in 2008, booked through an adventure-travel outfitter,
took them to theBwindi
Impenetrable Forest,
home to mountain gorillas. While there, the operators offered an
optional trip, to a place called the Maramagambo Forest, where the
chief attraction was a peculiar site known as Python Cave. African
rock pythons lived there, languid and content, grown large and fat
on a diet of bats.
Most
of the other travellers didn't fancy this trip, Taal told me. "But
Astrid and I always said, maybe you come here only once in your
life, and you have to do everything you can."
Inside
the cave, the footing was bad: rocky, uneven, slick with guano. The
ceiling was thick with bats, big ones, many thousands of them,
agitated at the presence of human intruders. Astrid and Jaap kept
their heads low and watched their step, trying not to slip, ready to
put a hand down if needed. "I think that's how Astrid got
infected," he told me. "I think she put her hand on a
piece of rock [covered with bat droppings]. And so she had it on her
hand."
No
one had warned Joosten and Taal about the potential hazards of
an African bat cave. They knew nothing of a virus
called Marburg,
first identified in 1967 and thought to be carried by bats
(though they had heard of Ebola,
another filovirus). They stayed in the cave for only about 10
minutes. Then they left, visited the mountain gorillas, did a boat
trip, and flew back to Amsterdam. Thirteen days after the cave
visit, at home in Noord-Brabant, Astrid fell ill.
At
first it seemed no worse than flu. Then her temperature went
higher and higher. After a few days she began suffering organ
failure. Her doctors suspectedLassa
fever and
moved her to a hospital in Leiden, where she developed a rash
and conjunctivitis; she haemorrhaged. She was put into an
induced coma, a move dictated by the need to dose her more
aggressively with antiviral medicine. Before she lost consciousness,
Taal went back into the isolation room, kissed his wife and said to
her, "Well, we'll see you in a few days." Blood samples,
sent to a lab in Hamburg, confirmed the diagnosis: Marburg.
Astrid worsened. As her organs shut down, she lacked oxygen to
the brain, suffered cerebral oedema, and before long she
was declared brain-dead. "They kept her alive for
a few more hours, until the family arrived," Taal
told me. "Then they pulled out the plug and she died
within a few minutes." The doctors, appalled by his
recklessness in kissing her goodbye, had prepared an isolation
room for Taal himself, but that was never needed.
The
news of Astrid Joosten's death carried far. She was the first person
known to have left Africa with an active filovirus infection
and died. Back in 1994, a Swiss graduate student from Ivory Coast
had recovered. Did any other person, apart from those two, ever pass
through an international airport and depart the continent with Ebola
or Marburg virus incubating in his or her body? No one of whom the
experts were aware. Astrid Joosten's case proved that Marburg could
travel in a human, though it didn't travel as well
as Sars or
influenza or HIV-1.
Five thousand miles away, in Colorado, another woman heard the news
with a shudder of recognition. She had visited Python Cave, too.
Astrid
Joosten fell ill after visiting a bat cave in Uganda and died of
Marburg within weeks. Photograph: Karlijn Bastiaansen/ED.nl
Infectious
disease is all around us. It's one of the basic processes that
ecologists study, along with predation and competition. Predators
are big beasts that eat their prey from outside. Pathogens
(disease-causing agents, such as viruses) are small beasts that eat
their prey from within. Although infectious disease can seem grisly
and dreadful, under ordinary conditions, it's every bit as natural
as what lions do to wildebeests and zebras. But conditions aren't
always ordinary.
Just
as predators have their accustomed prey, so do pathogens. And just
as a lion might occasionally depart from its normal behaviour –
to kill a cow instead of a wildebeest, or a human instead
of a zebra – so a pathogen can shift to a new target.
Aberrations occur. When a pathogen leaps from an animal into
a person, and succeeds in establishing itself as an
infectious presence, sometimes causing illness or death,
the result is a zoonosis.
It's
a mildly technical term, zoonosis, unfamiliar to most people, but it
helps clarify the biological complexities behind the ominous
headlines about swine flu, bird
flu, Sars,
emerging diseases in general, and the threat of a global pandemic.
It's a word of the future, destined for heavy use in the 21st
century.
Ebola
and Marburg are zoonoses. So is bubonic plague. So was the so-called
Spanish influenza of 1918–1919, which had its source in a wild
aquatic bird and emerged to kill as many as 50 million people.
All of the human influenzas are zoonoses. As are monkeypox, bovine
tuberculosis, Lyme
disease, West
Nile fever,
rabies and a strange new affliction called Nipah
encephalitis,
which has killed pigs and pig farmers in Malaysia. Each of these
zoonoses reflects the action of a pathogen that can
"spillover", crossing into people from other animals.
Aids
is a disease of zoonotic origin caused by a virus that, having
reached humans through a few accidental events in western and
central Africa, now passes human-to-human. This form of interspecies
leap is not rare; about 60% of all human infectious diseases
currently known either cross routinely or have recently crossed
between other animals and us. Some of those – notably rabies –
are familiar, widespread and still horrendously lethal, killing
humans by the thousands despite centuries of efforts at coping with
their effects. Others are new and inexplicably sporadic, claiming a
few victims or a few hundred, and then disappearing for years.
Zoonotic
pathogens can hide. The least conspicuous strategy is to lurk within
what's called a reservoir host: a living organism that carries the
pathogen while suffering little or no illness. When a disease seems
to disappear between outbreaks, it's often still lingering nearby,
within some reservoir host. A rodent? A bird? A butterfly? A bat? To
reside undetected is probably easiest wherever biological diversity
is high and the ecosystem is relatively undisturbed. The converse is
also true: ecological disturbance causes diseases to emerge. Shake a
tree and things fall out.
Michelle
Barnes is an energetic, late 40s-ish woman, an avid rock climber and
cyclist. Her auburn hair, she told me cheerily, came from a bottle.
It approximates the original colour, but the original is gone. In
2008, her hair started falling out; the rest went grey "pretty
much overnight". This was among the lesser effects of a mystery
illness that had nearly killed her during January that year, just
after she'd returned from Uganda.
Her
story paralleled the one Jaap Taal had told me about Astrid, with
several key differences – the main one being that Michelle Barnes
was still alive. Michelle and her husband, Rick Taylor, had wanted
to see mountain gorillas, too. Their guide had taken them through
Maramagambo Forest and into Python Cave. They, too, had to clamber
across those slippery boulders. As a rock climber, Barnes said, she
tends to be very conscious of where she places her hands. No, she
didn't touch any guano. No, she was not bumped by a bat. By late
afternoon they were back, watching the sunset. It was Christmas
evening 2007.
They
arrived home on New Year's Day. On 4 January, Barnes woke up
feeling as if someone had driven a needle into her skull. She was
achy all over, feverish. "And then, as the day went on,
I started developing a rash across my stomach." The rash
spread. "Over the next 48 hours, I just went down really fast."
By
the time Barnes turned up at a hospital in suburban Denver, she was
dehydrated; her white blood count was imperceptible; her kidneys and
liver had begun shutting down. An infectious disease specialist, Dr
Norman K Fujita, arranged for her to be tested for a range of
infections that might be contracted in Africa. All came back
negative, including the test for Marburg.
Gradually
her body regained strength and her organs began to recover. After 12
days, she left hospital, still weak and anaemic, still undiagnosed.
In March she saw Fujita on a follow-up visit and he had her serum
tested again for Marburg. Again, negative. Three more months passed,
and Barnes, now grey haired, lacking her old energy, suffering
abdominal pain, unable to focus, got an email from a journalist she
and Taylor had met on the Uganda trip, who had just seen a news
article. In the Netherlands, a woman had died of Marburg after
a Ugandan holiday during which she had visited a cave full of bats.
Michelle
Barnes and her husband, Rick Taylor, in Uganda, where she caught
Marburg
Barnes
spent the next 24 hours Googling every article on the case she could
find. Early the following Monday morning, she was back at Dr
Fujita's door. He agreed to test her a third time for Marburg. This
time a lab technician crosschecked the third sample, and then the
first sample.
The
new results went to Fujita, who called Barnes: "You're now an
honorary infectious disease doctor. You've self-diagnosed, and the
Marburg test came back positive."
The
Marburg virus had reappeared in Uganda in 2007. It was a small
outbreak, affecting four miners, one of whom died, working at a site
called Kitaka
Cave.
But Joosten's death, and Barnes's diagnosis, implied a change in the
potential scope of the situation. That local Ugandans were dying of
Marburg was a severe concern – sufficient to bring a response team
of scientists in haste. But if tourists, too, were involved,
tripping in and out of some python-infested Marburg repository,
unprotected, and then boarding their return flights to other
continents, the place was not just a peril for Ugandan miners
and their families. It was also an international threat.
The
first team of scientists had collected about 800 bats from Kitaka
Cave for dissecting and sampling, and marked and released more than
1,000, using beaded collars coded with a number. That team,
including scientist Brian Amman, had found live Marburg virus in
five bats.
Entering
Python Cave after Joosten's death, another team of scientists, again
including Amman, came across one of the beaded collars they had
placed on captured bats three months earlier and 30 miles away.
"It
confirmed my suspicions that these bats are moving," Amman said
– and moving not only through the forest but from one roosting
site to another. Travel of individual bats between far-flung roosts
implied circumstances whereby Marburg virus might ultimately be
transmitted all across Africa, from one bat encampment to another.
It voided the comforting assumption that this virus is strictly
localised. And it highlighted the complementary question: why don't
outbreaks of Marburg virus disease happen more often? Marburg is
only one instance to which that question applies. Why not more
Ebola? Why not more Sars?
In
the case of Sars, the scenario could have been very much worse.
Apart from the 2003 outbreak and the aftershock cases in early 2004,
it hasn't recurred… so far. Eight thousand cases are relatively
few for such an explosive infection; 774 people died, not 7
million. Several factors contributed to limiting the scope and
impact of the outbreak, of which humanity's good luck was only one.
Another was the speed and excellence of the laboratory diagnostics –
finding the virus and identifying it. Still another was the brisk
efficiency with which cases were isolated, contacts were traced and
quarantine measures were instituted, first in southern China, then
in Hong Kong, Singapore, Hanoi and Toronto. If the virus had arrived
in a different sort of big city – more loosely governed, full of
poor people, lacking first-rate medical institutions – it might
have burned through a much larger segment of humanity.
One
further factor, possibly the most crucial, was inherent in the way
Sars affects the human body: symptoms tend to appear in a person
before, rather than after, that person becomes highly infectious.
That allowed many Sars cases to be recognised, hospitalised and
placed in isolation before they hit their peak of infectivity. With
influenza and many other diseases, the order is reversed. That
probably helped account for the scale of worldwide misery and death
during the 1918–1919 influenza. And that infamous global pandemic
occurred in the era before globalisation. Everything nowadays moves
around the planet faster, including viruses. When the Next Big One
comes, it will likely conform to the same perverse pattern as the
1918 influenza: high infectivity preceding notable symptoms. That
will help it move through cities and airports like an angel of
death.
The
Next Big One is a subject that disease scientists around the world
often address. The most recent big one is Aids, of which the
eventual total bigness cannot even be predicted – about 30 million
deaths, 34 million living people infected, and with no end in sight.
Fortunately, not every virus goes airborne from one host to another.
If HIV-1 could, you and I might already be dead. If the
rabies virus could, it would be the most horrific pathogen on the
planet. The influenzas are well adapted for airborne transmission,
which is why a new strain can circle the world within days. The Sars
virus travels this route, too, or anyway by the respiratory droplets
of sneezes and coughs – hanging in the air of a hotel corridor,
moving through the cabin of an aeroplane – and that capacity,
combined with its case fatality rate of almost 10%, is what made it
so scary in 2003 to the people who understood it best.
A
worker disinfects a poultry farm in China after an outbreak of the
deadly H5N1 strain of bird flu in 2006. Photograph: China
Photos/Getty Images
Human-to-human
transmission is the crux. That capacity is what separates a bizarre,
awful, localised, intermittent and mysterious disease (such as
Ebola) from a global pandemic. Have you noticed the persistent,
low-level buzz about avian influenza, the strain known as H5N1,
among disease experts over the past 15 years? That's because avian
flu worries them deeply, though it hasn't caused many human
fatalities. Swine flu comes and goes periodically in the human
population (as it came and went during 2009), sometimes causing a
bad pandemic and sometimes (as in 2009) not so bad as expected; but
avian flu resides in a different category of menacing possibility.
It worries the flu scientists because they know that H5N1 influenza
is extremely virulent in people, with a high lethality. As yet,
there have been a relatively low number of cases, and it is poorly
transmissible, so far, from human to human. It'll kill you if you
catch it, very likely, but you're unlikely to catch it except by
butchering an infected chicken. But if H5N1 mutates or reassembles
itself in just the right way, if it adapts for human-to-human
transmission, it could become the biggest and fastest killer disease
since 1918.
It
got to Egypt in 2006 and has been especially problematic for that
country. As of August 2011, there were 151 confirmed cases, of which
52 were fatal. That represents more than a quarter of all the
world's known human cases of bird flu since H5N1 emerged in 1997.
But here's a critical fact: those unfortunate Egyptian patients all
seem to have acquired the virus directly from birds. This indicates
that the virus hasn't yet found an efficient way to pass from one
person to another.
Two
aspects of the situation are dangerous, according to biologist
Robert Webster. The first is that Egypt, given its recent political
upheavals, may be unable to staunch an outbreak of transmissible
avian flu, if one occurs. His second concern is shared by influenza
researchers and public health officials around the globe: with all
that mutating, with all that contact between people and their
infected birds, the virus could hit upon a genetic configuration
making it highly transmissible among people.
"As
long as H5N1 is out there in the world," Webster told me,
"there is the possibility of disaster… There is the
theoretical possibility that it can acquire the ability to transmit
human-to-human." He paused. "And then God help us."
We're
unique in the history of mammals. No other primate has ever weighed
upon the planet to anything like the degree we do. In
ecological terms, we are almost paradoxical: large-bodied and
long-lived but grotesquely abundant. We are an outbreak.
And
here's the thing about outbreaks: they end. In some cases they end
after many years, in others they end rather soon. In some cases they
end gradually, in others they end with a crash. In certain cases,
they end and recur and end again. Populations of tent caterpillars,
for example, seem to rise steeply and fall sharply on a cycle of
anywhere from five to 11 years. The crash endings are dramatic, and
for a long while they seemed mysterious. What could account for such
sudden and recurrent collapses? One possible factor is infectious
disease, and viruses in particular.
The
dangers presented by zoonoses are real and severe, but the degree of
uncertainties is also high. There's not a hope in hell, as
Webster told me, of predicting the nature and timing of the
next influenza pandemic. Too many factors vary randomly.
I
have asked not just Webster, but many other eminent disease
scientists the same two-part question: 1) will a new disease emerge,
in the near future, sufficiently virulent and transmissible to cause
a pandemic on the scale of Aids or the 1918 flu, killing tens of
millions of people?; and 2) if so, what does it look like and whence
does it come? Their answers to the first part have ranged from maybe
to probably. Their answers to the second have focused on various
viruses prone to mutation, especially those for which the reservoir
host is some kind of primate.
But
the difficulty of predicting precisely doesn't oblige us to remain
blind, unprepared and fatalistic. We can at least be vigilant; we
can be well prepared and quick to respond. The scientists are on
alert. They are our sentries. But we, too, should understand in some
measure the basic outlines and dynamics of the situation. We should
appreciate that these recent outbreaks of new diseases, as well as
the recurrence and spread of old ones, are part of a larger pattern,
and that humanity is responsible for generating that pattern. We
should recognise that they reflect things that we're doing, not just
things that are happening to us.
We
have increased our population to the level of 7 billion and beyond.
We live at high densities in many cities. We have penetrated, and
continue to penetrate, the last great forests and other wild
ecosystems of the planet. We cut our way through the Congo,
through the Amazon, through Borneo. We shake the trees,
figuratively and literally, and things fall out. We kill and butcher
and eat many of the wild animals found there. We settle in those
places, bringing in our domesticated animals. We multiply our
livestock as we've multiplied ourselves, under conditions that allow
them to acquire infections, to share them with one another, and to
infect humans. We export and import livestock across great
distances and at high speeds.
We
travel, moving between cities and continents even more quickly than
our transported livestock. We stay in hotels where strangers sneeze
and vomit. We eat in restaurants where the cook may have butchered a
porcupine before working on our scallops. We visit monkey temples in
Asia, live markets in India, picturesque villages in South America,
bat caves in East Africa – breathing the air, feeding the animals,
touching things, shaking hands with the friendly locals. And then we
jump on our planes and fly home.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.